Vancomycin PO

C. diff Risk

None

Oral Bioavailability

None

Approximate Cost

Spectrum Of Activity

Dosing

125 mg PO/NG/OG q6h for 10-14 days

Intra-colonic dose 500 mg in 100 mL of NS by rectal enema q6h (use with caution)

General Information

Common Usage

Only indication is therapy of C. difficile infection, particularly recurrent or severe disease

Pharmacology

Antimicrobial class: Glycopeptide

Pregnancy category: B

Average serum half life: 0.0

Urine penetration: None

Lung penetration: None

CSF penetration: None

Biliary penetration: None